Comparison of anti-peritoneal fibrotic effects between an mTORC1-specific blocker and a PI3K/mTOR dual-blocker
Objective: To compare the anti-peritoneal fibrotic effects between a mammalian target of rapamycin complex 1-specific blocker and a phosphatidyl-inositol 3-kinase/mammalian target of rapamycin dual-blocker. Methods: A total of 40 male Sprague-Dawley rats were randomly divided into five groups with e...
Main Authors: | Tian Xu, Tao Lin, Jingyuan Xie, Hong Ren, Nan Chen, Weiming Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-01-01
|
Series: | Renal Failure |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/0886022X.2019.1596818 |
Similar Items
-
Jagged-1 is induced by mTOR inhibitors in renal cancer cells through an Akt/ALK5/Smad4-dependent mechanism
by: David Danielpour, et al.
Published: (2022-01-01) -
Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells
by: Blaser Benjamin, et al.
Published: (2012-03-01) -
Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma
by: Ming-Huei Chou, et al.
Published: (2021-03-01) -
Synergistic Effects of Combination Therapy with AKT and mTOR Inhibitors on Bladder Cancer Cells
by: Hyera Kim, et al.
Published: (2020-04-01) -
The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens
by: Yi-Ying Wu, et al.
Published: (2019-07-01)